Neurodegenerative Disease

Researching the molecular mechanisms involved in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).

Translating findings in human patient samples into improved drug therapies for ALS patients.

Uncovering the complex molecular pathways linking environmental factors like diet and chronic stress to the immune responses in neurological disorders.

Identifying ways to reduce the risk for Alzheimer's disease and dementia.

Studying mild cognitive impairment, which is a precursor to Alzheimer’s disease (AD), Down syndrome, and traumatic brain injury (TBI).

Focusing on applied Alzheimer's research, including drug development and drug repurposing to achieve new treatments for Alzheimer's disease.

Exploring the cellular and molecular mechanisms of neurodegeneration in central nervous system disorders such as amyotrophic lateral sclerosis and frontotemporal dementia